Product nameAnti-HIV1 gp120 antibody
See all HIV1 gp120 primary antibodies
DescriptionGoat polyclonal to HIV1 gp120
Tested applicationsSuitable for: Conjugation, ELISA, WBmore details
Species reactivityReacts with: Species independent
Purified native gp120 from strain IIIB.
Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Storage bufferpH: 7.20
Preservative: 0.1% Sodium azide
Constituent: 0.0268% PBS
Concentration information loading...
Purification notesPurified by Sodium sulfate precipitation and ion-exchange chromatography. >95% pure.
Our Abpromise guarantee covers the use of ab21179 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|Conjugation||Use at an assay dependent dilution.|
|ELISA||Use at an assay dependent dilution.|
|WB||1/1000. Predicted molecular weight: 120 kDa. Dilution optimised using Chromogenic detection|
RelevanceHIV1 is equipped with the envelope gp160 glycoprotein for interaction with Langerhans cells (LCs) and dendritic cells (DCs), the members of the innate immune system, which confront the virus at the portal of virus entry in the human body. These cells are equipped with receptors by which they bind and endocytose the virus. The gp120 glycoprotein is used for binding to CD4 receptor and CCR5 co-receptor of T helper 2 (Th2) cells, and is able to induce FcepsilonRI(+) hematopoietic cells to produce IL4, which inactivates the host adaptive immune response.
Cellular localizationEnvelope surface glycoprotein.
- Glycoprotein 120 antibody
- gp120 antibody
- SU antibody
- Surface protein antibody
This product has been referenced in:
- Domljanovic I et al. Complexes of DNA with fluorescent dyes are effective reagents for detection of autoimmune antibodies. Sci Rep 7:1925 (2017). Read more (PubMed: 28507286) »
- Safavieh M et al. Paper microchip with a graphene-modified silver nano-composite electrode for electrical sensing of microbial pathogens. Nanoscale 9:1852-1861 (2017). Read more (PubMed: 27845796) »